Identification of human leucocyte antigen (HLA)-A*0201-restricted cytotoxic T lymphocyte epitopes derived from HLA-DOβ as a novel target for multiple myeloma-Reference-Cited by-同舟云学术

Identification of human leucocyte antigen (HLA)-A*0201-restricted cytotoxic T lymphocyte epitopes derived from HLA-DOβ as a novel target for multiple myeloma

Published:2013-08-30 Issue:3 Volume:163 Page:343-351
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Kang Yoon Joong,Zeng Wanyong,Song Weihua¹,Reinhold Bruce,Choi Jaewon²,Brusic Vladimir,Yamashita Takuto³,Munshi Aditya¹,Li Cheng⁴,Minvielle Stephane⁵,Anderson Kenneth C.¹,Munshi Nikhil¹,Reinherz Ellis L.,Sasada Tetsuro

Affiliation:

1. Department of Medical Oncology; Dana-Farber Cancer Institute; Harvard Medical School; Boston; MA; USA

2. Cancer Vaccine Center; Dana-Farber Cancer Institute; Harvard Medical School; Boston; MA; USA

3. Biostatistics Centre; Kurume University Graduate School of Medicine; Kurume; Fukuoka; Japan

4. Department of Biostatistics and Computational Biology; Dana-Farber Cancer Institute; Harvard Medical School; Boston; MA; USA

5. INSERM UMR 892; CNRS UMR 6299; University of Nantes; Nantes; France

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.12544/fullpdf

Reference37 articles.

1. Impaired tumor antigen processing by immunoproteasome-expressing CD40-activated B cells and dendritic cells;Anderson;Cancer Immunology, Immunotherapy,2011

2. Novel epitope evoking CD138 antigen-specific cytotoxic T lymphocytes targeting multiple myeloma and other plasma cell disorders;Bae;British Journal of Haematology,2011

3. A novel immunogenic CS1-specific peptide inducing antigen-specific cytotoxic T lymphocytes targeting multiple myeloma;Bae;British Journal of Haematology,2012

4. The epithelial tumor antigen MUC1 is expressed in hematological malignancies and is recognized by MUC1-specific cytotoxic T-lymphocytes;Brossart;Cancer Research,2001

5. MHC class II molecules in tumour immunology: prognostic marker and target for immune modulation;Chamuleau;Immunobiology,2006

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Construction of immune-related gene pairs signature to predict the overall survival of multiple myeloma patients based on whole bone marrow gene expression profiling;Molecular Genetics and Genomics;2024-04-22

2. Integration of Transcriptome and Epigenome to Identify and Develop Prognostic Markers for Ovarian Cancer;Journal of Oncology;2022-08-30

3. Therapeutic Cancer Vaccines—Antigen Discovery and Adjuvant Delivery Platforms;Pharmaceutics;2022-07-11

4. Identification and Verification of Necroptosis-Related Gene Signature With Prognosis and Tumor Immune Microenvironment in Ovarian Cancer;Frontiers in Immunology;2022-06-24

5. Construction of a Macrophage Infiltration Regulatory Network and Related Prognostic Model of High-Grade Serous Ovarian Cancer;Journal of Oncology;2021-11-24